AREDS 2 Formula & Macular Carotenoid Physics: Optical Density of Lutein & Zeaxanthin

The human macula lutea (literally 'yellow spot') derives its vibrant color from three specific xanthophyll carotenoid isomers:

• Meso-Zeaxanthin: Concentrated at the absolute epicentric core of the fovea (0° to 1°).
• Zeaxanthin: Dominates the parafovea (1° to 2°).
• Lutein: Extends across the perifovea (2° to 6°).

These carotenoids possess conjugated polyene backbones with a peak optical absorption spectrum between 445 nm and 460 nm:

\text{Absorption Peak: } \lambda_{\max} \approx 460\ \text{nm} \quad [\text{High-Energy Visible Screen & Solar Blue}]

By physically absorbing up to 90% of incident short-wavelength blue photons before they reach the mitochondrial respiratory chain of photoreceptors, macular pigment extinguishes phototoxic oxidative stress.

The AREDS 2 clinical trial definitively optimized the daily nutritional cocktail:

1. Lutein: 10 mg
2. Zeaxanthin: 2 mg
3. Vitamin C: 500 mg
4. Vitamin E: 400 IU
5. Zinc (as Zinc Oxide): 80 mg (or 25 mg lower dose)
6. Copper (as Cupric Oxide): 2 mg (prevents zinc-induced copper deficiency anemia)

Critically, AREDS 2 completely eliminated Beta-Carotene, which had been shown in AREDS 1 to significantly increase the risk of fatal lung cancer in smokers and former smokers.

Clinical eye clinics measure macular pigment using Heterochromatic Flicker Photometry (HFP):

A blue light (absorbed by pigment) and green light (unabsorbed) are alternated at 15 Hz. The patient adjusts luminance until flicker vanishes, calculating the MPOD value:

• Low MPOD ($< 0.20$): Dangerous optical vulnerability; high risk of AMD progression.
• Optimal MPOD ($> 0.50$): Dense optical shield, enhancing contrast sensitivity and glare recovery.

Combining AREDS 2 supplementation with ELLASUV certified blue-filtering ophthalmic lenses creates a dual-layer external and internal defense against phototoxic retinal degeneration.